AEMD AETHLON MEDICAL INC

Nasdaq aethlonmedical.com


$ 1.79 $ -0.19 (-9.39 %)    

Friday, 13-Jun-2025 20:10:41 EDT
QQQ na $ -6.70 (-1.26 %)
DIA na $ -7.49 (-1.74 %)
SPY na $ -6.31 (-1.05 %)
TLT na $ -1.01 (-1.16 %)
GLD na $ 4.23 (1.35 %)
$ 1.76
$ 1.79
-- x --
-- x --
$ 1.79 - $ 1.79
$ 1.75 - $ 8.44
67,450
na
3.18M
$ 1.74
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-12-2025 12-31-2024 10-Q
2 11-13-2024 09-30-2024 10-Q
3 08-14-2024 06-30-2024 10-Q
4 06-27-2024 03-31-2024 10-K
5 02-14-2024 12-31-2023 10-Q
6 11-14-2023 09-30-2023 10-Q
7 08-10-2023 06-30-2023 10-Q
8 06-28-2023 03-31-2023 10-K
9 02-13-2023 12-31-2022 10-Q
10 11-14-2022 09-30-2022 10-Q
11 08-09-2022 06-30-2022 10-Q
12 06-28-2022 03-31-2022 10-K
13 02-14-2022 12-31-2021 10-Q
14 11-09-2021 09-30-2021 10-Q
15 08-09-2021 06-30-2021 10-Q
16 06-24-2021 03-31-2021 10-K
17 02-10-2021 12-31-2020 10-Q
18 10-28-2020 09-30-2020 10-Q
19 08-11-2020 06-30-2020 10-Q
20 06-25-2020 03-31-2020 10-K
21 02-10-2020 12-31-2019 10-Q
22 11-01-2019 09-30-2019 10-Q
23 08-14-2019 06-30-2019 10-Q
24 07-01-2019 03-31-2019 10-K
25 02-11-2019 12-31-2018 10-Q
26 11-06-2018 09-30-2018 10-Q
27 08-08-2018 06-30-2018 10-Q
28 06-08-2018 03-31-2018 10-K
29 02-01-2018 12-31-2017 10-Q
30 11-02-2017 09-30-2017 10-Q
31 08-10-2017 06-30-2017 10-Q
32 06-28-2017 03-31-2017 10-K
33 02-10-2017 12-31-2016 10-Q
34 11-10-2016 09-30-2016 10-Q
35 08-11-2016 06-30-2016 10-Q
36 06-29-2016 03-31-2016 10-K
37 02-04-2016 12-31-2015 10-Q
38 11-16-2015 09-30-2015 10-Q
39 08-13-2015 06-30-2015 10-Q
40 06-26-2015 03-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 aethlon-medical-has-been-granted-european-patent-number-ep4136453-titled-lectin-for-use-in-methods-for-treating-a-sequela-of-coronavirus-infection

https://register.epo.org/application?number=EP21788894

Core News & Articles

https://www.who.int/news/item/09-06-2025-fourth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-rega...

 aethlon-medical-announces-poster-presentation-at-keystone-symposium-on-long-covid-and-other-post-acute-infection-syndromes-presentation-reviews-hemopurifier-affinity-resins-ability-to-bind-extracellular-vesicles-in-long-covid-samples

Poster Presentation Reviews the Hemopurifier® Affinity Resin's Ability to Bind Extracellular Vesicles in Long COVID Samples...

 aethlon-medical-publishes-preclinical-data-showing-ability-of-hemopurifier-to-remove-platelet-derived-extracellular-vesicles-from-plasma

Results Reinforce the Current Australian Oncology Clinical Trial and Support Investigation of the Hemopurifier Across Multiple ...

 watching-aethlon-medical-traders-circulate-article-from-biorxiv-ex-vivo-removal-of-cd41-positive-platelet-microparticles-from-plasma-by-a-medical-device-containing-a-galanthus-nivalis-agglutinin-gna-affinity-resin-aethlon-medicals-hemopurifier

https://www.biorxiv.org/content/10.1101/2025.05.09.652772v1

 hc-wainwright--co-reiterates-buy-on-aethlon-medical-maintains-7-price-target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Aethlon Medical (NASDAQ:AEMD) with a Buy and maintains $7 price...

 aethlon-medical-publishes-preclinical-data-on-the-hemopurifier-in-transplant-immunology-journal-entitled--a-lectin-affinity-plasmapheresis-device-removes-extracellular-vesicles-and-micrornas-from-renal-perfusates-following-controlled-oxygenated-rewarming-of-discarded-donor-kidneys

Preclinical Data Suggests Expanded Therapeutic Potential of the Hemopurifier® Beyond Virology and OncologyResults Support Furth...

 hc-wainwright--co-reiterates-buy-on-aethlon-medical-maintains-7-price-target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Aethlon Medical (NASDAQ:AEMD) with a Buy and maintains $7 price...

 aethlon-medical-q3-eps-013-beats-020-estimate

Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.2...

 hc-wainwright--co-reiterates-buy-on-aethlon-medical-maintains-7-price-target

HC Wainwright & Co. analyst Vernon Bernardino reiterates Aethlon Medical (NASDAQ:AEMD) with a Buy and maintains $7 price...

Core News & Articles

https://www.manchestereveningnews.co.uk/news/health/new-case-mpox-detected-uk-30876004 A new case of Mpox has been confirmed in...

Core News & Articles

https://www.washingtonpost.com/health/2025/01/16/bird-flu-testing-patients-in-hospital/ The Centers for Disease Control and Pre...

Core News & Articles

https://ldh.la.gov/news/H5N1-death#:~:text=The%20Louisiana%20Department%20of%20Health,to%20have%20underlying%20medical%20condit...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION